Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01622582

Enrollment

796

Registered

2012-06-19

Start date

2006-01-31

Completion date

2013-03-31

Last updated

2015-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

Keywords

Multiple Myeloma, Engraftment syndrome

Brief summary

Engraftment Syndrome after Autologous Stem Cell Transplant: Retrospective Review in Patients with Multiple Myeloma

Detailed description

A retrospective chart review series will be performed fpr subjects enrolled from 1/1/2006.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with Multiple Myeloma, developing engraftment syndrome

Exclusion criteria

* Patients with Multiple Myeloma, with no features of engraftment syndrome

Design outcomes

Primary

Measure	Time frame	Description
number of patients developing Engraftment syndrome following stem cell transplant	6 months post-transplant	A retrospective review where subjects medical records are studied for development of engraftment syndrome 6 months after stem cell transplant

Countries

United States

Outcome results